Mutations in exon 2 showed a particularly high rate of somatic alterations (70% of uterine leiomyomas) [64] and have been shown to disrupt the direct interaction of MED12 with the cyclin C-CDK8 leading to reduced Mediator activity [66]. This evidence concerns the gene CCNC and uterine corpus leiomyoma.